Pacst News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pacst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pacst Today - Breaking & Trending Today
Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.75 and traded as high as $3.08. Acasti Pharma shares last traded at $2.96, with a volume of 13,180 shares trading hands. Analyst Ratings Changes Separately, Craig […] ....
Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 3,800 shares, an increase of 171.4% from the March 31st total of 1,400 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average trading volume […] ....
Shares of Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.65 and traded as high as $3.41. Acasti Pharma shares last traded at $3.38, with a volume of 34,601 shares traded. Wall Street Analysts Forecast Growth […] ....
Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Down 6.1 % Shares of Acasti Pharma stock opened at $2.45 on Wednesday. Acasti Pharma has a 1 […] ....
Acasti Pharma (NASDAQ:ACST – Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Performance ACST stock opened at $2.61 on Tuesday. Acasti Pharma has a one year low […] ....